1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Inflammatory Bowel Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baskind, H; De Plaen, IG; Hsueh, W; Liu, SX; Tian, R | 1 |
| Guo, J; Sun, M; Teng, X; Xu, LF | 1 |
| De Plaen, IG; Han, XB; Hsueh, W; Liu, X | 1 |
| Rios, A; Torres, MI | 1 |
| Appleyard, CB; Hillier, K | 1 |
| Belogi, L; Cavallo, G; Croce, C; Guida, G; Modesti, A; Santiangeli, C; Tubaro, E | 1 |
| Murphy, G | 1 |
| Kaminski, DL; Longo, WE; Mazuski, JE; Nassif, A; Vernava, AM | 1 |
| Meenan, J; Stronkhorst, A; Tytgat, GN; van Deventer, SJ; van Dullemen, H | 1 |
| Benvensite, J; Chaussade, S; Colombel, JF; Couturier, D; Denizot, Y | 1 |
| MacDermott, RP; Raedler, A; Schreiber, S; Stenson, WF | 1 |
| Stenson, WF | 1 |
4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.
Topics: Animals; Apoptosis; Cytokines; Diet; Dietary Fiber; Fatty Acids, Unsaturated; Flavonoids; Humans; Immune System; Inflammatory Bowel Diseases; Models, Genetic; Platelet Activating Factor; Probiotics; Reactive Oxygen Species | 2008 |
Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.
Topics: Animals; Cytokines; Humans; Inflammatory Bowel Diseases; Platelet Activating Factor | 1996 |
Mediators of mucosal inflammation: implications for therapy.
Topics: Arachidonic Acid; Cytokines; Eicosanoids; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Platelet Activating Factor | 1997 |
The role of the mucosal immune system in inflammatory bowel disease.
Topics: Antibody Formation; Bacterial Toxins; Complement Pathway, Alternative; Complement Pathway, Classical; Cytokines; Cytotoxicity, Immunologic; Free Radicals; Granulocytes; Histamine; Humans; Immunity, Cellular; Immunoglobulins; Inflammatory Bowel Diseases; Intestinal Mucosa; Leukotrienes; Lymphocyte Activation; Macrophages; Mast Cells; Oxygen; Platelet Activating Factor; Prostaglandins; T-Lymphocytes | 1992 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice.
Topics: Animals; Chemokine CXCL2; Disease Models, Animal; Hypotension; I-kappa B Proteins; Ileum; Inflammation Mediators; Inflammatory Bowel Diseases; Mice; Mice, Knockout; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Platelet Activating Factor; Protein Processing, Post-Translational; Splanchnic Circulation; Time Factors; Tumor Necrosis Factors; Up-Regulation | 2009 |
Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor.
Topics: Biological Transport; Caco-2 Cells; Cell Line, Tumor; Claudin-1; Electric Impedance; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Membrane Potentials; Membrane Proteins; Peptides; Phosphoproteins; Platelet Activating Factor; Tight Junctions; Trefoil Factor-2; Zonula Occludens-1 Protein | 2012 |
Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor.
Topics: Animals; Antibodies, Blocking; Chemokine CXCL2; Chemokines; Chemokines, CXC; Gene Expression Regulation; Hematocrit; Hypotension; Ileum; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Leukocyte Count; Leukopenia; Male; Monokines; Neutrophil Infiltration; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Biosynthesis of platelet-activating factor in normal and inflamed human colon mucosa: evidence for the involvement of the pathway of platelet-activating factor synthesis de novo in inflammatory bowel disease.
Topics: Aged; Azepines; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Colon; Culture Techniques; Cytidine Diphosphate Choline; Female; Glyceryl Ethers; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Triazoles | 1995 |
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.
Topics: Animals; Arachidonic Acid; Carbohydrate Sequence; Colitis; Colon; Gangliosides; Humans; Inflammatory Bowel Diseases; Leukotriene B4; Male; Malondialdehyde; Molecular Sequence Data; Organ Size; Pancreas; Peroxidase; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Spleen; Synovial Fluid; Trinitrobenzenesulfonic Acid | 1993 |
Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease.
Topics: Cytokines; Humans; Inflammatory Bowel Diseases; Leukotrienes; Platelet Activating Factor; T-Lymphocytes | 1993 |
Paf-acether in stool as marker of intestinal inflammation.
Topics: Feces; Humans; Inflammatory Bowel Diseases; Platelet Activating Factor | 1992 |
Platelet-activating factor and inflammatory bowel disease.
Topics: Animals; Cell Membrane; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Platelet Activating Factor | 1988 |